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The Notch signaling pathway is critically involved in cell fate decisions during development of many tissues and organs. In the
present study we employed in vivo and cell culture models to elucidate the role of Notch signaling in wound healing. The
healing of full-thickness dermal wounds was significantly delayed in Notch antisense transgenic mice and in normal mice
treated with c-secretase inhibitors that block proteolytic cleavage and activation of Notch. In contrast, mice treated with
a Notch ligand Jagged peptide showed significantly enhanced wound healing compared to controls. Activation or inhibition of
Notch signaling altered the behaviors of cultured vascular endothelial cells, keratinocytes and fibroblasts in a scratch wound
healing model in ways consistent with roles for Notch signaling in wound healing functions all three cell types. These results
suggest that Notch signaling plays important roles in wound healing and tissue repair, and that targeting the Notch pathway
might provide a novel strategy for treatment of wounds and for modulation of angiogenesis in other pathological conditions.
Citation: Chigurupati S, Arumugam TV, Son TG, Lathia JD, Jameel S, et al (2007) Involvement of Notch Signaling in Wound Healing. PLoS ONE 2(11):
e1167. doi:10.1371/journal.pone.0001167
INTRODUCTION
Notch-1 (Notch) is a cell surface receptor that regulates cell fate
decisions during development; depending on the cell type and
context, Notch signaling induces differentiation or maintains cells
in an undifferentiated proliferating state [1–4]. Binding of ligands
of the Delta or Jagged families results in proteolytic cleavages of
Notch, first in an extracellular domain and then in the
transmembrane domain. The latter cleavage is accomplished by
the c-secretase enzyme complex resulting in the release of a Notch
intracellular domain (NICD) that translocates to the nucleus where
it regulates transcription [5]. Growing evidence implicates Notch
signaling in the regulation of tissue homeostasis in adults. For
example, Notch regulates lymphocyte expansion and immune
function [6], synaptic plasticity [7] and neural cell responses to
injury [8] in the adult rodent brain. Notch signaling is also
involved in angiogenesis, the formation of new blood vessels [9–
11]. Mutations of Notch receptors and ligands in mice lead to
abnormalities in many tissues, including the vascular system. It was
shown that mice lacking Notch [10] or the Notch ligand Jagged-1
[11] die during embryonic development as a result of vascular
plexus remodeling defects. Similarly, haploinsufficiency of Jagged-
1 in humans results in Alagille syndrome, characterized among
other things by congenital vascular abnormalities that are
a significant cause of mortality [12]. In addition, Notch signaling
regulates endothelial cell proliferation and migration during
angiogenesis in normal tissues and tumors [13–16].
Wound healing involves an initial inflammatory response and
subsequent changes in keratinocytes, fibroblasts and vascular
endothelial cells that close the wound and regenerate the skin tissue
[17].AlthoughitisnotknownifNotchplaysaroleinwoundhealing,
recent studies demonstrated the expression of Notch and the Notch
ligands Jagged-1 and Jagged-2 and Notch in vascular endothelial
cells in situ [18]. In addition, Notch signaling has been reported to
affect angiogenesis [19,20]. Notch has also been shown to affect the
behaviors of keratinocytes, fibroblasts and platelets [21–25],
additional cell types that play important roles in wound healing.
In the present study we employed Notch antisense transgenic
mice (NAS), c-secretase enzyme inhibitors and the Notch ligand
Jagged-1 to elucidate the role of Notch signaling in wound
healing. Our data demonstrate a pivotal role for Notch signaling in
wound healing in vivo, as well as direct positive effects on
endothelial, keratinocyte and fibroblast cells. These findings reveal
Notch signaling as a novel therapeutic target for the treatment of
wounds.
RESULTS
Wound healing is impaired in Notch antisense
transgenic mice and normal mice treated with a
c-secretase inhibitor and enhanced in mice treated
with Jagged-1 peptide
We first investigated the role of Notch in the wound healing
process by comparing the rate of dermal wound healing in mice
with reduced levels of Notch (NAS mice) and nontransgenic
control mice. In nontransgenic control mice, 4 mm full-thickness
dermal wounds healed rapidly with the lesions being reduced by
50% within 5 days, and were completely healed within 13 days
(Fig. 1a, b). In contrast, healing was delayed in NAS mice, with the
lesion size being decreased by only 15% at 5 days, and not being
completely healed at 13 days. We next treated the wounds of
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activation of Notch within cells involved in wound healing.
Compared to vehicle-treated control mice, those treated with
DAPT exhibited a significant delay in wound healing (Fig. 1a, c).
To further confirm the role of Notch signaling in wound healing,
we treated the wounds of normal mice with mouse Jagged-1
peptide to activate the Notch cells within the wound area. Mice
treated with Jagged peptide showed significantly enhanced wound
healing compared to vehicle-treated control animals (Fig. 1 a, c).
Reduced Notch signaling perturbs multiple cellular
events in the wound healing process
Detailed histopathological analysis of H&E sections showed
delayed wound healing in NAS animals at days 1, 3, 5, 8 and
13 post-injury compared to non transgenic control mice (Fig. 2
and see SI histological evaluation). On day 1, nontransgenic
control mice exhibited a superficial layer of the wound that was
lined by a thin layer of collagen, a damaged keratinocyte layer
with a distinct edema underneath with expanded space and fibrin
deposits; scattered mononuclear cells and neutrophils were
observed within the damaged tissue. On day 1, NAS mice
exhibited a larger fibrin-filled spaces and greater numbers of
mononuclear cells and neutrophil infiltrates compared to control
mice (Fig. 2). On day 3 the edema and fibrinous exudates had
resolved substantially in control mice, while mononuclear cells had
infiltrated in greater numbers into the interstitium and the dermal
layers. NAS mice on day 3 exhibited large numbers of cellular
infiltrates and necrotic tissue, and the hypodermis was expanded
with edema. On day 5 the wounds in control mice exhibited
distinct crusting (eschar), with the skin and wound junction evident
beneath the semi-attached crust. The keratinocyte layer was
absent at the wound site, but compared to day 3 the edema and
fibrin exudates were reduced, the collagen fibers were densely
packed and fibroblasts were visible in this matrix. Dense, irregular
collagen and minimal edema were observed under higher
magnification, and neo-vascularization was evident within the
wound site. On day 5, NAS mice had fewer fibers of collagen and
fewer migrating fibroblasts in the superficial dermis of the wound
site, and there was a thin layer of pre-keratinization (Fig. 2). Little
or no neovascularization of the wound site had occurred by post-
injury day 5 in NAS mice. On day 8 the wound site of control
mice contained large amounts of collagen in the dermis (scar
tissue) with few mononuclear cells and numerous distinct blood
vessels (Fig. 2). The keratinocyte layer had become well-formed
and edema and expanded interstitial spaces were absent. On day 8
the NAS mice exhibited prominent collagen deposition in the
superficial dermis, but it was less organized compared to control
mice. There were foci of dead cells and necrotic tissue on the
wound surface, and mononuclear cell infiltrates were still present
intermixed with collagen. Neovascularization was distinctly less
than in control mice. At day 13 the skin in the wounds of control
Figure 1. Genetic and pharmacological inhibition of Notch impairs wound healing. Two full-thickness dermal wounds were induced in NAS mice
and nontransgenic mice, vehicle-treated control mice, g-secretase inhibitor (GSI)-treated (100 mM DAPT) mice and 15 mM mouse Jagged peptide-
treated mice. a. Images of a representative mouse from each group taken on post-injury days 1, 3, 5, 8 and 13 are shown. b. Wound sizes at the
indicated time points in NAS and wild-type control mice (WT). c. Wound sizes at the indicated time points in control, GSI-treated and Jagged peptide-
treated mice. Values are the mean and SEM (n=6 mice per group). *p,0.001, #p,0.01 compared to the control value. Scale bar=4 mm.
doi:10.1371/journal.pone.0001167.g001
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layer, well organized dermis and adnexal structures. There was no
indication of inflammation (edema or cell infiltration). Wound
healing (eschar shedding and healthy granulation) appeared
complete. In contrast, the wounds of NAS mice were not
completely healed by day 13 as indicated by the presence of
dense collagen deposits in superficial and deeper dermis, and by
the presence of mononuclear cells infiltration. Keratinization was
in the initial stages. The keratinocyte layer of the wound site was
single-layered in comparison to the multilayered keratinocytes in
the healthy skin of the same animals (Fig. 2).
To confirm the involvement of Notch signaling in wound
healing, we examined H&E stained sections of skin from vehicle-
and DAPT and Jagged peptide-treated mice. The histological
changes described above for normal wound healing in control
mice were delayed in DAPT-treated mice and accelerated in
Jagged peptide-treated mice (Fig. 2; and see SI histological
evaluation). Collectively, the analyses of wound healing in NAS
mice, Jagged and DAPT-treated normal mice suggested that
Notch signaling plays important roles in several aspects of cellular
responses to dermal wounds including leukocyte infiltration,
angiogenesis and keratinocyte migration.
Notch is activated transiently in the skin in response
to wounding
To study the level of Notch signaling activity in response to Jagged
peptide treatment in different cell types involved in wound healing,
wemeasuredthelevelofNICDinendothelialcells,keratinocytesand
in fibroblasts. We used mouse embryonic stem cells which exhibit
high levels of Notch activity as a positive control. Treatment with
Jagged peptide significantly increased the level of NICD in all 3 skin
cell types (Fig. 3a, b). We next examined the level of NICD in skin
samples from the wound sites in NAS and control mice, and DAPT-,
Jagged peptide- and vehicle-treated mice. The levels of NICD were
significantly lower throughout the 13 day study period in NAS mice
compared to nontransgenic controls (Fig. 3c, d). The level of NICD
was decreased within 24 h of treatment with DAPT and remained
low through treatment day 13 (Fig. 3e, f). The levels of NICD in skin
samples from the wound area of Jagged peptide-treated mice were
significantly higher throughout the 13 day treatment period
compared to vehicle-treated control mice (Fig. 3g, h).
Notch signaling enhances vascular endothelial cell
proliferation, migration and tube formation
Because endothelial cells are critically involved in neovasculariza-
tion and the wound healing process, we determined the effects of
Notch activation and inhibition on the behaviors of cultured
human vascular endothelial cells. First, we confirmed that the
Notch signaling pathway was functional in endothelial cells,
fibroblasts and keratinocytes. This was accomplished by expressing
reporter constructs for the Notch target genes CBF-1 and Hes-1 in
cultured endothelial cells, keratinocytes and skin fibroblasts.
Activation of Notch with Jagged peptide increased CBF-1 and
Hes-1 expression in all three cell types (Figure S1).
Next, we determined the effects of c-secretase mediated Notch
signaling on the chemotaxis of vascular endothelial cells. Cells in 24-
well Transwell chamber assay cultures were treated with vehicle,
DAPT, Jagged peptide or SCP, and chemoattractant-induced cell
migration was quantified. The numbers of cells that migrated
through the transwell pores were significantly lower in DAPT-
Figure 2. Histological features of wound healing in mice with decreased or increased Notch activity. Images of skin tissue sections stained with
hematoxylin and eosin showing histological changes during the wound healing process in non-transgenic control mice, NAS mice, GSI (100 mM
DAPT) treated mice and 15 mM Jagged peptide-treated mice at post-injury days 1, 3, 5, 8 and 13. NAS and DAPT-treated mice exhibited delayed
wound healing, and Jagged peptide-treated exhibited enhanced wound healing, compared to control mice. See Supplementary histological
evaluation (Text S2) for a detailed description of histological changes in the different groups of mice. Scale bar=0.5 mm
doi:10.1371/journal.pone.0001167.g002
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PLoS ONE | www.plosone.org 3 November 2007 | Issue 11 | e1167Figure 3. Notch activity in skin cells is decreased in NAS mice and in response to c-secretase inhibition (10 mM), and is increased in response to
Jagged peptide treatment (15 mM). a and b. Representative immunoblot (a), and results of densitometric analysis of blots (b), showing relative
levels of NICD (80 kDa) and actin (42 kDa) in lysates (40 mg/lane) of cultured human vascular endothelial cells (HUVEC), mouse keratinocytes (KC) and
in mouse fibroblasts (MF) that had been treated for 6 h with vehicle or Jagged peptide. c and d. Representative immunoblot (c), and results of
densitometric analysis of blots (d), showing relative levels of NICD in skin tissue samples from NAS and control mice taken at the indicated post-
wounding time points. *p,0.01 compared to the control value. e and f. Representative immunoblot (e), and results of densitometric analysis of blots
(f), showing relative levels of NICD in skin tissue samples from control and c-secretase inhibitor (GSI)-treated mice taken at the indicated post-
wounding time points. g and h. Representative immunoblot (g), and results of densitometric analysis of blots (h), showing relative levels of NICD in
skin tissue samples from control and Jagged peptide-treated mice taken at the indicated post-wounding time points. *p,0.01 compared to the
control value (ANOVA p=and Newman-Keuls post hoc tests for pairwise comparisons).
doi:10.1371/journal.pone.0001167.g003
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contrast, Jagged peptide treatment resulted in a significant enhance-
ment of endothelial cell chemotaxis compared to SCP- and vehicle-
treated control cultures (Fig. 4a, b). We next examined the
endothelial cell migration in response to mechanical wound.
Endothelial cells in monolayer culture were subjected to mechanical
scratch wound injury in the absence or presence of the c-secretase
inhibitor DAPT (10 mM) to inhibit Notch or a Jagged peptide
(15 mM) to activate Notch. The numbers of cells that had migrated
into the cell-free wound zone during a 24 hour post-injury period
were quantified. Endothelial cell migration was inhibited by more
than 50% in cultured treated with DAPT compared to vehicle-
treated control cultures (Fig. 4c, d). Treatment of cultures with
Jagged peptide resulted in a significant increase in endothelial cell
migrationcomparedtocontrolcultures(Fig.4e,f).Toelucidatearole
for Notch signaling in angiogenesis, we employed an assay that
measures the formation of tubular capillary-like structures by
endothelial cells growing in a three-dimensional matrix. Cultures
were treated for 18 hours with vehicle, DAPT, Jagged peptide or
a control peptide with a scrambled amino acid sequence (SCP), and
tube formation was quantified. Both the number of capillary-like
structures and their total branch points were significantly lower in
DAPT-treated cultures compared to vehicle-treated control cultures
(Fig. 4g, h). In contrast, tube formation was significantly greater in
cultures treated with Jagged peptide compared to control cultures
treated with SCP (Fig. 4g, h). These results suggest a stimulatory
effect of Notch signaling on endothelial cell migration, and suggest
a rolefor Notchinangiogenesis during wound healing.Because both
proliferation and migration of cells is required for dermal wound
healing, we also assessed the effects of Notch inhibition and
activation on the proliferation of cultured vascular endothelial cells.
c-secretase inhibitor DAPT completely inhibited cell proliferation
during a 3 day treatment period, whereas Jagged peptide signifi-
cantly enhancethe cellproliferation rate compared to cells incontrol
cultures (Fig. 4i).
Notch signaling affects the migration of
keratinocytes and fibroblasts
As both keratinocytes and fibroblasts play major roles in skin wound
healing, we next determined the effects DAPT, Jagged peptide and
a scrambled control peptide on injury-induced cell migration in
monolayer cultures of keratinocytes and fibroblasts. Keratinocyte
migration was inhibited by more than 25% in cultures treated with
DAPT compared to vehicle-treated control cultures (Fig. 5a, b).
Interestingly, Jagged peptide treatment also significantly decreased
keratinocyte migration compared to control cultures (Fig. 5c, d).
Fibroblast migration was inhibited by more than 65% in culture
treated with DAPT (Fig. 5e, f), while Jagged peptide significantly
enhanced fibroblast migration (Fig. 5g, h). Neither DAPT nor
Jagged peptide significantly affected the proliferation rates of
keratinocytes or fibroblasts, although there was a trend towards
inhibition of proliferation with both treatments (Fig. 5i, j).
DISCUSSION
Our findings suggest that Notch signaling affects multiple cell types
involved in the skin injury response and dermal repair processes.
Wound healing was impaired in NAS mice and in normal mice
treated with a c-secretase inhibitor, and was enhanced in mice
treated with the Notch ligand Jagged, demonstrating a requirement
for Notch signaling for normal wound healing. The NAS mouse
models what partial loss of Notch does in multiple cell types. The
antisense cDNA was cloned in the Nhe1 and Xho1 sites of
pMAMneo, which was then linearized, SV40 sequences were
excised and linear DNA was injected into blastocysts F1 C57bl6/
SJL.Twoindependentfounderswere derived,bothcharacterizedby
lighter hair color than wild type littermates (silver and gold). These
were bred back into the C57bl6 background for several generations,
segregating by PCR done on tail DNA. The antisense is expressed in
skin where the only observable phenotype is a discoloration of the
hair to a lighter color [26,27]. Notch signaling is highly dose-
dependent. For example, Notch signaling can either maintain the
undifferentiated status or promote differentiation of neural stem cells
depending on magnitude and duration of activation [28]. Our study
design is therefore of therapeutic relevance because it shows what
a systemic but partial Notch inhibition does, which is what is likely to
happen with GSI treatment in the clinic.
Notch signaling affected several behaviors of vascular endothe-
lial cells that are critical for angiogenesis, a process critical for
tissue repair as a wound heals [29–32]. Angiogenesis involves
endothelial cell migration into the surrounding tissue, cell
proliferation, alignment and tube formation, recruitment of
parenchymal cells and a return to quiescence [30–32]. Activation
of Notch with a Jagged peptide enhanced vascular endothelial cell
proliferation, migration and tube formation, whereas treatment
with a c-secretase inhibitor suppressed all three behaviors of the
endothelial cells. While previous studies indicated a role for Notch
in angiogenesis in tumors [33,34], the present findings are the first
to document the involvement of Notch in angiogenesis triggered
by dermal injury. Compounds that promote angiogenesis have
been reported to enhance wound healing [35]. However, little is
known regarding the signaling mechanisms involved in regulating
the different stages of an angiogenic response that can be targeted
for the development of novel treatments for wounds. Our findings
suggest Notch as a novel target for therapeutic intervention to
enhance wound healing.
The initial response to wounding is typically the formation of
a blood clot, which together with local damaged tissue, releases
proinflammatory signals which trigger the infiltration of in-
flammatory cells including neutrophils and macrophages. These
signals and those from the invading inflammatory cells influence
both re-epithelialisation and connective tissue contraction of the
wound [36]. The inflammatory response may exacerbate tissue
damage, but is not essential for skin wound healing [37]. We found
that the infiltration of inflammatory cells into the damaged tissue
was decreased in NAS mice and by treatment with a c-secretase
inhibitor, suggesting a key role for Notch signaling in the
inflammatory cell responses. Indeed, it was recently reported that
Notch signaling is pivotal for the recruitment and activation of
leukocytes and microglia to the site of tissue injury following an
ischemic stroke in mice [8]. Other studies have also suggested roles
for Notch signaling in inflammatory processes including the
activation of macrophages [38] and suppression of airway
inflammation [39]. Enhancement by Notch of inflammatory cell
recruitment and activation would be expected to exacerbate the
initial tissue damage.
Our findings also suggest roles for c-secretase and Notch
signaling in regulating the behaviors of keratinocytes and
fibroblasts, two additional cell types involved in dermal wound
healing. Migration of these cells following injury was significantly
reduced when c-secretase was inhibited. Studies of cultured
fibroblasts have indeed shown that activation of Notch alters cell
migration [40]. We found that activation of Notch with a Jagged
peptide enhanced the migration of endothelial cells and fibroblasts,
but inhibited the migration of keratinocytes. Although the Notch
target genes that regulate cell behaviors during wound healing
remain to be established, we did establish that Notch activation
results in induction of the Notch target genes CBF-1 and Hes-1 in
Notch Regulates Wound Healing
PLoS ONE | www.plosone.org 5 November 2007 | Issue 11 | e1167Figure 4. Notch signaling regulates the motility and proliferation of vascular endothelial cells. a and b. Cultured human vascular endothelial cells
(HUVEC) were treated with either vehicle (Control), g-secretase inhibitor (GSI; 10 mM DAPT) or Jagged peptide (15 mM) in conditioned medium and
plated into chemo-attractant medium consisting regular growth medium with 10% FBS and other growth factors and cell migration was evaluated
using a 24 well Transwell chamber assay. Representative images are shown in panel and a and quantitative data are shown in panel b (values are the
mean6SEM for cells per 1006field; n=3-4). *p,0.001 compared to control values. #p,0.001 compared to SCP values. c–f. HUVEC monolayers were
mechanically wounded with the sterile tip of a 20–200 ml pipette tip following treatment with vehicle, GSI (10 mM DAPT), scrambled control peptide
(SCP; 15 mM) or Jagged peptide (15 mM). Representative images are shown in c and e, and quantitative data on cell migration in d and f. Values are
the mean and SEM (n=3 separate experiments). *p,0.001. g and h. HUVEC were seeded on Matrigel-precoated wells and cultured in the presence of
low-serum medium with GSI (10 mM DAPT), SCP (15 mM) or Jagged peptide (15 mM). Tube formation, designated as the number of branch points/
1006field) was evaluated 18h after cell plating. Representative images are shown in g and quantitative data in h. Values are the mean and SEM
(n=12–16 cultures). *p,0.001. i. Cultured HUVEC were treated with GSI (10 mM DAPT), scrambled peptide (SCP; 15 mM) or Jagged peptide (15 mM)
for the indicated time periods and relative cell numbers were estimated (n=4–6 experiments). *p,0.001, #p,0.01 compared to the control cultures.
doi:10.1371/journal.pone.0001167.g004
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PLoS ONE | www.plosone.org 6 November 2007 | Issue 11 | e1167Figure 5. Evidence that Notch signaling regulates the behaviors of keratinocytes and skin fibroblasts. a–h. Monolayers of cultured keratinocytes
(a–d) or fibroblasts (e–h) were treated with vehicle (Control), GSI (10 mM DAPT), 15 mM SCP or 15 mM Jagged peptide, and were then subjected to
scratch wounding. Eighteen hours after wounding, images of the wound area were acquired and the number of cells per field that had migrated into
the cell-free wound zone were determined for each culture. Representative images (a, c, e, g) and quantitative data (b, d, f, h) are shown. Values are
the mean and SEM (n=3 separate experiments). *p,0.001. i and j. Cultured keratinocytes (i) and fibroblasts (j) were treated with vehicle (Control),
GSI (10 mM DAPT), 15 mM SCP or 15 mM Jagged peptide for the indicated time periods and relative cell numbers were estimated. Values are the mean
and SEM (n=4–6 experiments).
doi:10.1371/journal.pone.0001167.g005
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has been reported that activation of Notch signaling in keratinocytes
is sufficient to cause cell cycle withdrawal, through induction of
p21
WAF1/Cip1 and expression of terminal differentiation markers of
the intermediate epidermal layers [21]. The latter findings are
consistent with our observation that keratinocyte migration was
reduced in response to Jagged peptide.
Okuyama and colleagues [41] provided evidence that Notch
accounts in part for the high commitment of embryonic
keratinocytes to terminal differentiation. Another study showed
that soluble form of Jagged1 induced the differentiation of cultured
keratinocytes [42]. Levels of Jagged-1 and Notch increased during
the differentiation process, and may trigger keratinocyte terminal
differentiation and cornification [24]. However, we found that
GSI treatment also significantly reduced keratinocyte migration,
suggesting that Notch signaling is important for keratinocyte
migration and differentiation in wound healing. Our data suggest
a beneficial role for Notch signaling in angiogenesis, fibroblast and
keratinocyte migration and terminal differentiation in wound
healing. It will be of considerable interest to identify the gene
targets of Notch in vascular endothelial cells, keratinocytes and
skin fibroblasts that promote cell migration and differentiation.
MATERIALS AND METHODS
Mice
The generation and characterization of transgenic mice in which
a Notch antisense sequence is expressed under the control of the
mouse mammary tumor virus long terminal repeat promoter has
been described previously [43]. Notch protein levels are decreased
by approximately 50% in various tissues of these mice, including
the skin. The genetic background and breeding scheme for these
mice are described in the Supplemental Methods online (Text S1).
Dermal Wounds and Quantification of Healing
Mice were anesthetized using 2 to 2.5% vaporized inhaled
isoflurane and the dorsal skin was cleansed with Betadine. Full-
thickness dermal wounds were created in the skin on the back of
the mouse using a 4-mm biopsy punch (Miltex Instrument, York,
PA, USA) and a biotome (Acu Punch, Acuderm Inc., Fort
Lauderdale, FL, USA). Mice were treated with vehicle (10 mlo f
dimethylsulfoxide) or 100 mM of the c-secretase inhibitor DAPT
(N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl
ester) (Chemicon, Temecula, CA, USA) [44] and 15 mM mouse
jagged peptide (Washington Biotechnology, MD, USA) applied
directly to the wound site once daily in a blinded manner. Some
mice in each group were euthanized on days 1, 3, 5 and 8 post
wounding, and skin tissue samples from the wound site were
collected from all of the mice for histological and biochemical
analyses. Some animals from each genotype/treatment group
(n=6–8) were evaluated daily for 13 days following wounding.
Digital photographs of the injury site were taken with a standard-
sized dot placed beside the wound; wound size was expressed as
the ratio of the wound area to the dot measurement.
Histology
To assess cellular infiltration into the wounded area, samples from
three mice per group were collected on days 1, 3, 5, 8 and 13
during the healing process. To obtain skin samples from the
biopsied areas, mice were euthanized with an overdose of sodium
pentobarbital and the tissues were subsequently removed by
dissection. Formalin-fixed samples were sectioned at 4 mm and
stained with hematoxylin and eosin. All the slides were evaluated
by a veterinary pathologist in blinded manner.
Immunoblot analysis
Tissue protein was extracted using T-PER tissue protein extraction
buffer with protease inhibitor cocktail (Sigma). Details of the
immunoblot protocol are included in the Supplemental Methods
online (Text S1).
Endothelial cell scratch wound healing assay
Human umbilical vein endothelial cells (HUVECs), Human
keratinocytes (CRL-2309, ATCC, VA, USA) and mouse fibroblasts
were seeded into 60 mm plates and grown to confluency. After
24 hours of serum starvation (DMEM supplemented with 1% FBS),
cells were treated with either vehicle or scrambled peptide (controls),
DAPT (10 mM) or Jagged-1 peptide (15 mM). The amino sequence of
the scrambled control peptide was RCGPDCFDNYGRYKYCF,
and the sequence of the Jagged-1 peptide was CDDYYYGFGCNK-
FGRPRDD. The cell monolayer was then subjected to a mechanical
scratch-wound induced using a sterile pipette tip. Cells were then
cultured for additional period of 24 hours in a serum-free basal
medium in the presence of controls, DAPT or Jagged peptide. Cells
were then fixed in a solution of 4% paraformaldehyde in PBS and
stained with crystal violet. Cells in the injury area were visualized
under phase-contrast optics (106objective) and the number of cells
which had migrated into the initially cell-free scratch are was
counted.
Endothelial tube formation and chemotaxis cell
migration assays
These assays were performed using methods similar to those
described previously [45]; details are provided in the Supplemen-
tal Methods online (Text S1).
Quantification of cell proliferation
The proliferation of cultured endothelial cells, keratinocytes and
fibroblasts was measured using a colorimetric assay with 3-(4, 5-
dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT). Details are provided in the
SUPPORTING INFORMATION
Text S1
Found at: doi:10.1371/journal.pone.0001167.s001 (0.02 MB
DOC)
Text S2
Found at: doi:10.1371/journal.pone.0001167.s002 (0.02 MB
DOC)
Figure S1 Jagged peptide increases the levels of the Notch
downstream gene target products CBF-1 and Hes-1 in endothelial,
keratinocyte and fibroblast cells. HUVEC, keratinocytes and
fibroblasts were treated with Jagged peptide or vehicle control and
analyzed for CBF-1 and Hes1 using luciferase reporter assays.
*p,0.05, **p,0.01 and ***p,0.001 compared to control value.
Found at: doi:10.1371/journal.pone.0001167.s003 (0.07 MB TIF)
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